tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Stringer, 242 are a BUY (97.58%), 6 are a HOLD (2.42%).
Analyst Joseph Stringer, currently employed at NEEDHAM, carries an average stock price target met ratio of 33.85% that have a potential upside of 31.48% achieved within 121 days.
Joseph Stringer’s has documented 485 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 21-Mar-2025.
Analyst best performing recommendations are on RNA (AVIDITY BIOSCIENCES ).
The best stock recommendation documented was for RNA (AVIDITY BIOSCIENCES ) at 6/10/2024. The price target of $35 was fulfilled within 2 days with a profit of $7.89 (29.1%) receiving and performance score of 145.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$54
$29.86 (123.70%)
$57
23 days ago
(04-Mar-2025)
12/21 (57.14%)
$28.85 (114.71%)
382
Hold
$29
$4.86 (20.13%)
$30
23 days ago
(04-Mar-2025)
16/20 (80%)
$3.85 (15.31%)
136
Hold
$25
$0.86 (3.56%)
$26
23 days ago
(04-Mar-2025)
5/5 (100%)
$-0.15 (-0.60%)
42
Hold
$32
$7.86 (32.56%)
$36
23 days ago
(04-Mar-2025)
1/10 (10%)
$6.85 (27.24%)
24
Buy
$57
$32.86 (136.12%)
$57
23 days ago
(04-Mar-2025)
3/22 (13.64%)
$31.85 (126.64%)
108
Which stock is Joseph Stringer is most bullish on?
Which stock is Joseph Stringer is most reserved on?
What Year was the first public recommendation made by Joseph Stringer?
